[ad_1] AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with the Securities and Exchange Commission late Friday, which cited research and development expenses and…
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for marketing authorization in the European Union for advanced liver and lung cancer. The Anglo-Swedish pharma…
[ad_1] GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker…